Literature DB >> 18468667

Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys.

Heather L Kimmel1, S Stevens Negus, Kristin M Wilcox, Sarah B Ewing, Jeffrey Stehouwer, Mark M Goodman, John R Votaw, Nancy K Mello, F Ivy Carroll, Leonard L Howell.   

Abstract

Although inhibition of dopamine transporters (DAT) and the subsequent increase in dopamine clearly play a role in the effects of psychomotor stimulants, the reinforcing effectiveness of DAT inhibitors varies. Previous studies suggest that pharmacokinetic and pharmacodynamic properties of these drugs account for this variability. The present studies compared the time course and behavioral effects of five phenyltropane analogs of cocaine with high affinity for DAT and varying time courses of action in rhesus monkeys. The rate of drug uptake in putamen was measured using positron emission tomography neuroimaging. The rank order of the time to peak drug uptake was cocaine<RTI-336<RTI-150<RTI-113<RTI-177. Cocaine and all five analogs fully substituted for the cocaine cue in animals trained to discriminate cocaine from saline. All of the drugs were self-administered under a progressive-ratio schedule of drug self-administration and reinstated previously extinguished self-administration maintained under a second-order schedule. The time to peak drug uptake corresponded closely with the time to peak discriminative stimulus effects, and there was a trend for the time of peak drug uptake to correspond negatively with the peak number of drug infusions. Collectively, these results indicate that the rate of drug entry in brain can play an important role in the behavioral pharmacology of psychomotor stimulants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468667      PMCID: PMC2453312          DOI: 10.1016/j.pbb.2008.03.032

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  39 in total

1.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior.

Authors:  M E Reith; B E Meisler; H Sershen; A Lajtha
Journal:  Biochem Pharmacol       Date:  1986-04-01       Impact factor: 5.858

3.  Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.

Authors:  L L Howell; L D Byrd
Journal:  J Pharmacol Exp Ther       Date:  1991-07-01       Impact factor: 4.030

4.  Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys.

Authors:  Joshua A Lile; Drake Morgan; Anne M Birmingham; Huw M L Davies; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

5.  Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.

Authors:  F Ivy Carroll; Neil Pawlush; Michael J Kuhar; Gerald T Pollard; James L Howard
Journal:  J Med Chem       Date:  2004-01-15       Impact factor: 7.446

6.  Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.

Authors:  B K Madras; M A Fahey; J Bergman; D R Canfield; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

7.  Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.

Authors:  J Bergman; B K Madras; S E Johnson; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

8.  The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics.

Authors:  Joshua A Lile; Zhixia Wang; William L Woolverton; Jessica E France; Timothy C Gregg; Huw M L Davies; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2003-09-03       Impact factor: 4.030

9.  Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.

Authors:  R D Spealman; B K Madras; J Bergman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

10.  Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.

Authors:  Kimberly P Lindsey; Kristin M Wilcox; John R Votaw; Mark M Goodman; Christophe Plisson; F Ivy Carroll; Kenner C Rice; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2004-02-24       Impact factor: 4.030

View more
  32 in total

1.  Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates.

Authors:  Paul W Czoty; Jennifer L Martelle; F Ivy Carroll; Michael A Nader
Journal:  Pharmacol Biochem Behav       Date:  2010-05-24       Impact factor: 3.533

Review 2.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Nonhuman primate positron emission tomography neuroimaging in drug abuse research.

Authors:  Leonard Lee Howell; Kevin Sean Murnane
Journal:  J Pharmacol Exp Ther       Date:  2011-02-11       Impact factor: 4.030

4.  Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.

Authors:  David R Schulze; F Ivy Carroll; Lance R McMahon
Journal:  Psychopharmacology (Berl)       Date:  2012-02-29       Impact factor: 4.530

5.  Models of neurological disease (substance abuse): self-administration in monkeys.

Authors:  Donna M Platt; Galen Carey; Roger D Spealman
Journal:  Curr Protoc Pharmacol       Date:  2011-12

6.  Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.

Authors:  Jeffrey S Stehouwer; Lauryn M Daniel; Ping Chen; Ronald J Voll; Larry Williams; Susan J Plott; John R Votaw; Michael J Owens; Leonard Howell; Mark M Goodman
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

Review 7.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

8.  Dopamine transporter-related effects of modafinil in rhesus monkeys.

Authors:  Monica L Andersen; Eileen Kessler; Kevin S Murnane; Jessica C McClung; Sergio Tufik; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

9.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

Review 10.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.